News
Hydroxychloroquine-triggered QTc-interval prolongations mount in COVID-19 patients
May 4, 2020
Two single-center reports further documented the incidence of QTc-interval prolongations in COVID-19 patients treated with hydroxychloroquine.
News
Out-of-hospital cardiac arrests soar during COVID-19 in Italy
May 1, 2020
Four provinces in northern Italy report increases of various magnitudes, ranging from 18% to a stunning 187%.
News
New study of diabetes drug for COVID-19 raises eyebrows
May 1, 2020
Some question the safety of AstraZeneca’s just-launched DARE-19 study testing whether dapagliflozin will reduce adverse outcomes of COVID-19.
News
Yale’s COVID-19 inpatient protocol: Hydroxychloroquine plus/minus tocilizumab
April 30, 2020
Yale cardiologist offers lessons from “the haze of battle” on fighting COVID-19 with little evidence.
News
Survey: Hydroxychloroquine use fairly common in COVID-19
April 29, 2020
Testing and preparedness have increased, but a return to normal life could take another 6 months.
News
SGLT2 inhibitor ertugliflozin shows no CV death or renal benefit
April 29, 2020
Merck reports topline results from ertugliflozin’s FDA-mandated cardiovascular outcomes trial.
News
Consensus recommendations on AMI management during COVID-19
April 28, 2020
The ACC, ACEP, and SCAI recommend a systematic approach for the care of patients with an acute myocardial infarction during the COVID-19 pandemic.
News
Seniors with COVID-19 show unusual symptoms, doctors say
April 27, 2020
The age group most at risk of severe complications may not have fever, insistent cough, or shortness of breath.
News
COVID-19 linked to large vessel stroke in young adults
April 27, 2020
The virus appears to cause disease through a process of blood clotting, according to an expert.
News
FDA reiterates hydroxychloroquine limitations for COVID-19
April 24, 2020
An FDA Safety Communication restates that hydroxychloroquine and chloroquine are only for hospitalized COVID-19 patients who can’t enter a trial.